Previous 10 | Next 10 |
2023-04-16 01:22:24 ET Summary Regeneron's Dupixent reported a 30% reduction in COPD exacerbation at week 52, while ensifentrine reported a 36% and 42% reduction in the ENHANCE-1 and ENHANCE-2 trials, respectively. Ensifentrine's broader inclusion criteria and lower cost as a smal...
2023-04-14 20:21:38 ET The S&P 500 ( SP500 ) on Friday closed 0.79% higher for the week, posting gains in two sessions, losses in two and ending flat in one. Its accompanying SPDR S&P 500 Trust ETF ( NYSEARCA: SPY ) advanced 0.80% for the week. The benchmark ...
2023-04-14 11:28:52 ET Summary Pharmaceuticals/biotechnology is the only subsector with good value and quality scores. Healthcare equipment is the most overvalued one. IXJ: A global alternative to XLV. 10 stocks cheaper than their peers in April. This monthly art...
2023-04-13 11:06:08 ET Summary Earnings season is getting going, and options traders are not expecting much single-stock volatility. I see shares of ISRG as not far from fair value given its growth outlook. The medtech's chart remains strong after defending support last Octobe...
2023-04-13 08:01:47 ET Summary MorphoSys completed enrollment for MANIFEST-2, a Phase 3 study exploring the safety and efficacy of pelabresib in combination with ruxolitinib for JAK inhibitor-naïve patients with myelofibrosis. The topline data of the MANIFEST-2 is expected by...
2023-04-12 16:31:23 ET Summary Structure Therapeutics has a promising pipeline of product candidates, including GSBR-1290, a GLP-1R agonist for diabetes and obesity, and APJR and LPA1R agonists and antagonists for various indications. The company has several competitive advantages...
2023-04-12 15:06:33 ET Summary The early euphoria in pre-market trading about the March CPI report has dissipated as the S&P 500's near-term momentum stalled (again) at a critical juncture. We assess that the tech sector (26% of SPY's weighting) is looking increasingly likely ...
2023-04-12 02:26:28 ET Summary The White House's announcement on drug price caps caused a significant drop in biopharma stocks during Q1 2023. The impact of drug pricing-related caps and pressure will likely be limited, and the industry is expected to adapt and find new revenue st...
2023-04-12 02:06:29 ET Summary Cathie Wood's ARKG provides investors with an opportunity to take advantage of the billion-dollar genomics market. However, it has performed poorly compared to XLV's higher-quality holdings in a period where the Fed has aggressively hiked interest ra...
2023-04-10 10:00:00 ET Summary Medtronic's investors endured a steep selloff in early March but formed a constructive bottom, lending optimism to its battered holders. We assessed that MDT buyers returned to defend the lows last seen in December and not give them up. The compa...
News, Short Squeeze, Breakout and More Instantly...
SPDR Select Sector Fund - Health Care Company Name:
XLV Stock Symbol:
NYSE Market:
2024-07-09 10:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-29 11:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-09 09:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...